While We Wait for a Vaccine Against SARS-CoV-2, Why Not Think About Available Drugs?

doi 10.20944/preprints202004.0087.v1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

The SARS-CoV-2 Vaccine Pipeline: An Overview

Current Tropical Medicine Reports
Infectious DiseasesAllergyImmunology
2020English

Fully Human Single-Domain Antibodies Against SARS-CoV-2

2020English

Can an Effective SARS-CoV-2 Vaccine Be Developed for the Older Population?

Immunity and Ageing
AgingImmunology
2020English

Open Questions for Harnessing Autophagy-Modulating Drugs in the SARS-CoV-2 War

2020English

Reinfection Could Not Occur in SARS-CoV-2 Infected Rhesus Macaques

2020English

Intrauterine Vertical Transmission of SARS-CoV-2: What We Know So Far

Ultrasound in Obstetrics and Gynecology
Nuclear MedicineRadiologyUltrasound TechnologyGynecologyReproductive MedicineRadiologicalImagingObstetricsMedicine
2020English

Hypothesis: Advanced Biotechnological Treatment Approaches Against SARS-CoV-2 (COVID-19)

Volume 5 - 2020, Issue 4 - April
2020English

Why Should We Think of Structural Injustice When Speaking About Culture?

2014English

SARS-COV-2 and Infectivity

Journal of Medical Virology
VirologyInfectious Diseases
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy